Search Results
Sarah B Goldberg, MD, MPH Assistant Professor of Medicine (Medical Oncology)
Dr. Goldberg on PD-L1 as a Biomarker in Lung Cancer
Sarah B. Goldberg Discusses New Immunotherapy Options for Patients With Lung Cancer
Dr. Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer
Sarah Goldberg, MD, MPH, Yale Cancer Center/Smilow Cancer Hospital
Dr. Goldberg on Managing CNS Metastases in Oncogene-Driven NSCLC
Dr. Goldberg on Immune/Targeted Therapy Combos in Oncogene-Driven Lung Cancer
Considering the Role of Clinical Trials for Patients With Molecularly-Altered Lung Cancer
Dr. Goldberg Discusses Treatment Approaches for Mesothelioma
Repeat biopsies in Lung Cancer - How Important Are They?
Treating NSCLC Patients Without an Actionable Oncogenic Driver
The Potential Role of Immunotherapy in the Management of Breast Cancer
